David A Moscatelli

Title: The Innovations of David A. Moscatelli

Introduction

David A. Moscatelli is a notable inventor based in New York, NY (US), recognized for his contributions to the field of biotechnology. He holds two patents that focus on angiogenic factors, which play a crucial role in various biological processes, including wound healing and tissue regeneration.

Latest Patents

Moscatelli's latest patents include a DNA sequence encoding a basic fibroblast growth factor. This isolated DNA sequence encodes an angiogenic factor protein that possesses mitotic and chemotactic activity, as well as the ability to stimulate protease synthesis. The protein consists of a single-polypeptide-chain and is designed to enhance the healing process in tissues. Another significant patent is for a purified, single-polypeptide-chain protein that exhibits substantial homology to the native angiogenic factor found in human placental tissues. This factor is characterized by its mitogenic and chemotactic activities, making it a valuable asset in pharmaceutical preparations.

Career Highlights

Throughout his career, Moscatelli has worked with prominent organizations such as Synergen, Inc. and New York University. His work has significantly advanced the understanding of angiogenic factors and their applications in medicine.

Collaborations

Moscatelli has collaborated with esteemed colleagues, including Daniel B. Rifkin and Andreas Sommer, contributing to the advancement of research in his field.

Conclusion

David A. Moscatelli's innovative work in the field of biotechnology, particularly in the development of angiogenic factors, has made a lasting impact on medical science. His patents reflect a commitment to enhancing therapeutic options for various health conditions.